No Data
No Data
No Data
No Data
No Data
Impressive Earnings May Not Tell The Whole Story For Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) stock was strong after they recently reported robust earnings. However, our analysis suggests that shareholders may be missing some
Simply Wall StMay 2 18:59 ET
These 4 Measures Indicate That Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Is Using Debt Safely
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Simply Wall StMay 1 03:21 ET
Revenue from main products such as Genipip surged, and the net profit of Sansheng Guojian (688336.SH) surged 171.88% in the first quarter to 91.191,000 yuan
According to Zhitong Finance App News, Sansheng Guojian (688336.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 267 million yuan, an increase of 28.72%; net profit attributable to shareholders of listed companies was 91.191,000 yuan, a year-on-year increase of 171.88%; net profit attributable to shareholders of listed companies deducted 857.583 million yuan for non-recurring profit and loss, a year-on-year increase of 203.60%; basic earnings per share were 0.15 yuan/share. In the first quarter of 2024, sales of the company's main products were good, R&D projects progressed smoothly, and internal operations continued to be efficient
Zhitong FinanceApr 25 04:51 ET
Sansheng Guojian (688336.SH): Non-net profit of 857.583 million yuan in the first quarter increased 203.6% year over year
Gelonghui, April 25 | Sansheng Guojian (688336.SH) released its first quarter report. Operating revenue was 267 million yuan, up 28.72% year on year, net profit of 911.191,000 yuan, up 171.88% year on year, after deducting non-net profit of 857.583 million yuan, up 203.6% year on year, with basic earnings of 0.15 yuan per share.
Gelonghui FinanceApr 25 04:45 ET
Is The Market Rewarding Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) has had a rough month with its share price down 8.0%. It seems that the market might have completely ignored the positive aspects of the comp
Simply Wall StApr 4 18:51 ET
Zhongtai Securities: Q1 results are about to be implemented, gradually focus on the pharmaceutical sector and individual stocks with improved Q2 performance
Zhongtai Securities said that at present, the overall market is still at a relative bottom. After experiencing a long-term correction, the pharmaceutical sector is also at multiple bottoms in terms of fundamentals, policies, and capital, and is firmly optimistic about the pharmaceutical sector market throughout the year.
Zhitong FinanceApr 1 05:02 ET
No Data
No Data